Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction

Background: Heart failure is the most common cause of hospitalization in elderly patients. It is likely that many of the mechanisms that contribute to reductions in systolic and diastolic function, seen in diabetic patients, place them at an increased risk of heart failure. Diuretic therapy, especia...

Full description

Bibliographic Details
Main Authors: Ayman Ibrahim, Ramadan Ghaleb, Hossam Mansour, Amr Hanafy, Naggeh M. Mahmoud, Mohamed Abdelfatah Elsharef, Mohamed Kamal Salama, Saud M. Elsaughier, Lobna Abdel-Wahid, Mona Embarek Mohamed, Ahmed K. Ibrahim, Ahmed Abdel-Galeel
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
dapagliflozin
furosemide
diuretic
heart failure
diabetes mellitus
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.602251/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2020.602251/full

Similar Items